Showing results (591-600 of 1,794) with videos related to

Sort By:
Pageof 180
International Journal of Molecular Medicine|June 6, 2007
A novel IRF6 nonsense mutation (Y67X) in a German family with Van der Woude syndromeSibylle Brosch, Manuela Baur, Nikolaus Blin, et al.
Bioinformatics (Oxford, England)|July 17, 2014
Gustaf: Detecting and correctly classifying SVs in the NGS twilight zoneKathrin Trappe, Anne-Katrin Emde, Hans-Christian Ehrlich, et al.
Journal of Cranio-Maxillo-Facial Surgery : Official Publication of the European Association for Cranio-Maxillo-Facial Surgery|April 7, 2015
Morphological analysis of the lip and nose following cleft lip repair with simultaneous partial primary rhinoplasty: A prospective study over 4 yearsSusanne Kluba, Christoph Bopp, Margit Bacher, et al.
Deutsche Zahnarztliche Zeitschrift|December 1, 1990
[The microplate system: a new armamentarium for osteosynthesis in the child skull]S Reinert, C U Fritzemeier, H G Luhr, et al.
The Orthopedic Clinics of North America|November 25, 2010
Percutaneous treatment of pelvic and acetabular fractures in obese patientsPeter Bates, Joshua Gary, Gurpreet Singh, et al.
Phytotherapy Research : PTR|September 3, 2010
Mistletoe lectin-I augments antiproliferative effects of the PPARgamma agonist rosiglitazone on human malignant melanoma cellsChristian Freudlsperger, Anka Dahl, Juergen Hoffmann, et al.
Stem Cells International|February 3, 2018
Platelet Lysate: The Better Choice for Jaw Periosteal Cell MineralizationYvonne Wanner, Felix Umrath, Marc Waidmann, et al.
The Journal of Craniofacial Surgery|September 28, 2006
Computer-assisted surgical treatment of orbitozygomatic fracturesCarsten Westendorff, Dirk Gülicher, Florian Dammann, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 11, 2006
Cerebellar cortical molecular layer inhibition is organized in parasagittal zonesWangcai Gao, Gang Chen, Kenneth C Reinert, et al.
Clinical Breast Cancer|May 16, 2021
Real-world Data on First-line Systemic Therapy for Hormone Receptor-positive HER2-negative Metastatic Breast Cancer: A Trend Shift in the Era of CDK 4/6 InhibitorsGustavo Werutsky, Tomás Reinert, Mahira Lopes Rosa, et al.
Pageof 180